NOTV(Delisted)
Stock Fundamental
Valuation7.3/10
BullishKey Valuation Metric
PE Method: NOTV's market cap is approximately 2.79M with TTM earnings of -8.70B, corresponding to a PE ratio of -0.0. Compared to the Life Sciences Tools & Services industry average, this valuation may be undervalued.
PS Method: NOTV's market cap is approximately 2.79M with a PS ratio of 0.0. Compared to the Life Sciences Tools & Services industry average, this valuation may be undervalued.
PEG Method: With a PE of -0.0 and forward PE of -0.0, the PEG ratio comes to 0.88, indicating a undervalued valuation.
Historical Price to Earnings Ratio
Historical data shows that NOTV's P/E reached a peak of about -0.03 on 2026-06-10, and a trough of about -8.57 on 2024-03-25. The current P/E is -0.03, which places it at approximately the 100% percentile of its historical range, indicating a relatively overvalued valuation.
Share Price vs Future Cash Flow Value
NOTV's current stock price is about $0.10, while its Discounted Cash Flow valuation is about $0.27. Based on the Discounted Cash Flow model, the market price represents a discount to its intrinsic value.
Future Growth7.0/10
NeutralEarnings and Revenue Growth Forecasts
NOTV's Revenue moved from about 105.79M (2024) to about 117.65M (2026) in recent actuals. Analyst forecasts include about 129.79M, 130.94M, and 132.09M for the next forecast periods, implying an overall 3-year CAGR of roughly 3.9% versus the latest actual—indicating a fluctuating trend in Revenue..
Future Return on Equity
Analysts predict NOTV's future return on equity (Future ROE) will be about -54.9% over the next three years, lower than the Life Sciences Tools & Services industry average of -39.7%, indicating its backward position in capital profitability. A higher Future ROE generally reflects stronger expected profitability on shareholder equity, subject to business risk and accounting differences.
Past Performance1.7/10
BearishRevenue & Expenses Breakdown
NOTV's revenue primarily comes from Product, Service, — and —. Among these, Product accounts for 54.6%; Service for 45.4%, — for 0.0% and — for 0.0%. The company's main business is relatively concentrated.
Earnings & Revenue
- Earnings per share (TTM)-2.72
- Gross margin20.95%
- Net profit margin-27.60%
- Debt / equity8.11x
The company's earnings quality is weaker. Net profit for the latest fiscal period is about -32.47M, while free cash flow is estimated at 6.37M. The 38.84M difference between the two indicates significant cash conversion capabilities. suggesting a meaningful gap between accounting earnings and cash generation, often driven by non-cash items or working capital.
Free Cash Flow vs Earnings Analysis
NOTV's net income is about -16.23M, while free cash flow is about 6.37M, representing a FCF/Earnings ratio of -39.3%. The conversion from earnings to free cash flow is weak, indicating significant non-cash items or working capital effects may be pressuring cash conversion.
Financial Health2.0/10
BearishDebt to Equity History and Analysis
In 2026-03, total liabilities (Debt) are about 625.32M; total equity (Equity) is about 77.10M. These figures come from the financial health diagnose series (debt / equity). They describe capital structure, not operating earnings.
Balance Sheet
Assets
Liabilities + Equity
The company's shareholders' equity is $77.10M, representing about 11.0% of total assets, while total debt is $85.03M, representing about 12.1% of total assets. This low-leverage structure means expansion relies primarily on profits and equity capital, resulting in lower financial risk.
Dividends4.0/10
NeutralStability and Growth of Payments
NOTV is not paying a notable dividend in the U.S. market context; detailed stability and growth checks are less relevant until distributions become material.
Dividend Yield vs Market
NOTV's current dividend yield is 0.00%, while the Life Sciences Tools & Services industry average is around 1.15%. The top 25% of companies in the entire US market have a dividend yield of 0.75%, while the bottom 25% have a yield of 0.30%. In comparison, NOTV is clearly at the bottom of the industry.
Earnings Payout to Shareholders
Earnings coverage: NOTV is not paying a notable dividend for the US market.
Cash Payout to Shareholders
Cash flow coverage: NOTV is not paying a notable dividend for the US market.
- Based on a composite score of 3.88/10, we rate NOTV as a Netural. Our analysis breaks down into 0.49/10 for Fundamentals, 1.15/10 for Technicals, and 6.08/10 for Sentiment, indicating the stock is likely to consolidate sideways.
- Based on a composite score of 3.88/10, we rate NOTV as a Netural. Our analysis breaks down into 0.49/10 for Fundamentals, 1.15/10 for Technicals, and 6.08/10 for Sentiment, indicating the stock is likely to consolidate sideways.
